| 1)                                           Patients with both classical MP-positive a | 
| 2)                                           Patients with filigree-predominant ADC sho | 
| 3)                                           Patients with malignancy and solid-organ t | 
| 4)                                           Patients with pretreatment ApoC-II levels | 
| 5)                                           Patients with severe visual vertigo improv | 
| 6) ollected primary care records to identify patients with 'high-risk' conditions, incl | 
| 7)                     They are disrupted in patients with 22q11.2 deletion syndrome, d | 
| 8) is of single nuclei from brain tissues of patients with AD carrying the R47H mutatio | 
| 9)                      Therefore, subtyping patients with AD is a critical step toward | 
| 10) -Hispanic white individuals including 109 patients with AD, 356 mild cognitive impai | 
| 11) icrometastasis indicated poor survival in patients with ADC with the filigree patter | 
| 12)    Intrarenal scRNA-Seq transcriptomes in patients with AKI-defined cell populations | 
| 13) c EEG abnormalities are present in 80-90% patients with AS. | 
| 14)  and rituximab (FCR) in untreated younger patients with CLL. | 
| 15) l GCMH-related pathologies in smokers and patients with COPD. | 
| 16) that although approximately two-thirds of patients with COVID-19 had symptoms of kid | 
| 17) s in acutely meeting the medical needs of patients with COVID-19 while continuing es | 
| 18) ctive smokers were underrepresented among patients with COVID-19, claimed that a "sm | 
| 19) atinine was reported for up to 60% of the patients with COVID-19, the overall preval | 
| 20) nd clinical outcomes among critically ill patients with COVID-19. | 
| 21) is was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nation | 
| 22)           Conclusions: One-third of COVID patients with CVDRF required ICU care duri | 
| 23)       A cohort of 57 head-and-neck cancer patients with DECT and MRI pairs were used | 
| 24)                 The results revealed that patients with HGSOC and the TT genotype at | 
| 25)                               In summary, patients with HGSOC and the TT genotype at | 
| 26) at the rs6983267 locus (GG, GT, TT) in 98 patients with HGSOC. | 
| 27) associated with CKD but was restricted in patients with HIV viremia, regardless of C | 
| 28) onal consequence of six VUS identified in patients with IRD. | 
| 29) e presentation and clinical management of patients with IgAn in Europe and Japan. | 
| 30) es of these molecules in the NALT/BALT of patients with IgAn. | 
| 31) addition to the serious somatic symptoms, patients with MD also experience problems | 
| 32) itive functioning and/or mental health in patients with MD and their relatives. | 
| 33) itive impairments and mental disorders in patients with MD. | 
|  |